Automated Classification of Quality Defect Issues Relating to Substandard Medicines Using a Hybrid Machine Learning and Rule-Based Approach.
Desmond Chun Hwee TeoYiting HuangSreemanee Raaj DorajooMichelle Sau Yuen NgChih Tzer ChoongDoris Sock Tin PhuahDorothy Hooi Myn TanFilina Meixuan TanHuilin HuangMaggie Siok Hwee TanSuan Tian KohJalene Wang Woon PohPei San AngPublished in: Drug safety (2023)
Post-market surveillance of substandard medicines remains a key activity for drug regulatory authorities. A combined machine learning algorithm with keyword-based model can help to prioritise the review of product quality defect issues in a timely manner.